flow study semaglutide trial kidney outcomes 2024 results Semaglutides Are Poised to Remake Chronic Disease Care FLOWing with the SemagluTIDE — – flow study semaglutide Research shows

What Clinical Trials Reveal About Semaglutide The efficacy of semaglutide is backed by extensive clinical research, most notably the landmark STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial program: Substantial Weight Reduction: Participants using therapeutic doses of semaglutide achieved an average body weight reduction of 15% to 20% over a 68-week period when paired with basic lifestyle guidance

Research published in the International Journal of Obesity found that semaglutide reduced visceral adipose tissue and improved the ratio of muscle mass to visceral fat

Study findings showed that oral semaglutide use was associated with significant improvements in blood sugar control, reduced body weight, improved several lipid markers, and reduced alanine aminotransferase (ALT), a liver enzyme marker, in study participants

Sandy, 52 Vyora Member Texas Arianne, 47 Vyora Member Washington Alyssa, 32 Vyora Member Vermont Amanda, 34 Vyora Member New Mexico Honest feedback from people experiencing the difference for themselves